Stock ALKEM ALKEM LABORATORIES LIMITED
Add to a list

ETFs Alkem Laboratories Limited

Stocks

ALKEM

INE540L01014

Pharmaceuticals

Market Closed -
NSE India S.E.
07:05:07 2026-09-11 EDT 		5-day change 1st Jan Change
5,087.50 INR -0.98% Intraday chart for Alkem Laboratories Limited -1.97% -7.61%
09-08 Alkem Laboratories Limited Launches Renocia Exo, India?s First Patented Ginsenoside Exosome-Based Hair Growth Serum CI
08-14 Alkem Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026

ETFs positioned on Alkem Laboratories Limited

Name YTD change Weight AuM
VANGUARD FTSE ALL-WORLD UCITS ETF - USD ETF Vanguard FTSE All-World UCITS ETF - USD
+12.69%-.--% 27,154 M€
DIMENSIONAL EMERGING MARKETS CORE EQUITY 2 ETF - USD ETF Dimensional Emerging Markets Core Equity 2 ETF - USD
+22.52%-.--% 9,273 M€
STATE STREET SPDR S&P EMERGING MARKETS CARBON AWARE ETF - AUD ETF State Street SPDR S&P Emerging Markets Carbon Aware ETF - AUD
-2.45%-.--% 21 M€
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
+7.71%-.--% 37 M€
CI GROWTH ASSET ALLOCATION ETF -CAD ETF CI Growth Asset Allocation ETF -CAD
+10.61%-.--% 67 M€
WISDOMTREE EMERGING MARKETS MULTIFACTOR FUND ETF - USD ETF WisdomTree Emerging Markets Multifactor Fund ETF - USD
+22.07%0.43% 180 M€
JPM INDIA RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF ACC - USD ETF JPM India Research Enhanced Index Equity Active UCITS ETF Acc - USD
-10.04%0.3% 99 M€
UBS MSCI INDIA UNIVERSAL UCITS ETF - USD ETF UBS MSCI India Universal UCITS ETF - USD
-11.77%0.22% 2 M€
ISHARES MSCI INDIA ETF - USD ETF iShares MSCI India ETF - USD
-10.14%0.2% 6,661 M€
JPMORGAN ETFS (IRELAND) ICAV - GLOBAL EMERGING MARKETS RESEARCH ENHANCED INDEX EQUITY SRI PARIS ALIGNED ACTIVE UCITS ETF DIST - USD ETF JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF Dist - USD
+29.53%0.2% 10 M€
JPMORGAN ETFS (IRELAND) ICAV - GLOBAL EMERGING MARKETS RESEARCH ENHANCED INDEX EQUITY SRI PARIS ALIGNED ACTIVE UCITS ETF ACC - EUR ETF JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF Acc - EUR
+30.68%0.2% 38 M€
JPMORGAN ETFS (IRELAND) ICAV - GLOBAL EMERGING MARKETS RESEARCH ENHANCED INDEX EQUITY SRI PARIS ALIGNED ACTIVE UCITS ETF ACC - USD ETF JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF Acc - USD
+30.50%0.2% 247 M€
ISHARES MSCI INDIA UCITS ETF ACCUMULATING - USD ETF iShares MSCI India UCITS ETF Accumulating - USD
-12.11%0.17% 5,254 M€
XTRACKERS NIFTY 500 INDIA ETF - USD ETF Xtrackers Nifty 500 India ETF - USD
-9.39%0.16% 5 M€
INVESCO INDIA ETF - USD ETF Invesco India ETF - USD
-19.99%0.15% 108 M€
FRANKLIN FTSE INDIA ETF DIST - USD ETF Franklin FTSE India ETF Dist - USD
-9.48%0.13% 2,692 M€
FRANKLIN FTSE INDIA UCITS ETF - ACC - USD ETF Franklin FTSE India UCITS ETF - Acc - USD
-8.19%0.13% 2,189 M€
ISHARES MSCI INDIA INDEX ETF iShares MSCI India Index
-12.97%0.12% 48 M€
XTRACKERS MSCI EMERGING MARKETS CLIMATE TRANSITION UCITS ETF 1C - USD ETF Xtrackers MSCI Emerging Markets Climate Transition UCITS ETF 1C - USD
+25.76%0.11% 42 M€
FIDELITY EMERGING MARKETS EQUITY RESEARCH ENHANCED UCITS ETF ACC - USD ETF Fidelity Emerging Markets Equity Research Enhanced UCITS ETF Acc - USD
+26.31%0.11% 4,366 M€
WISDOMTREE EMERGING MARKETS QUALITY DIVIDEND GROWTH FUND - USD ETF WisdomTree Emerging Markets Quality Dividend Growth Fund - USD
+32.30%0.09% 148 M€
ISHARES MSCI EM ISLAMIC UCITS ETF - USD ETF iShares MSCI EM Islamic UCITS ETF - USD
+52.58%0.07% 794 M€
ISHARES MSCI EM CONSUMER GROWTH UCITS ETF - USD ETF iShares MSCI EM Consumer Growth UCITS ETF - USD
-7.15%0.07% 44 M€
HSBC MSCI EMERGING MARKETS ISLAMIC SCREENED CAPPED UCITS ETF (ACC) - USD ETF HSBC MSCI Emerging Markets Islamic Screened Capped UCITS ETF (Acc) - USD
+67.59%0.06% 173 M€
ISHARES MSCI BIC ETF - USD ETF iShares MSCI BIC ETF - USD
-9.06%0.06% 77 M€
FRANKLIN FTSE EMERGING EX CHINA UCITS ETF - USD ETF Franklin FTSE Emerging ex China UCITS ETF - USD
-.--%0.04% 7 M€
VANGUARD FTSE ASIA EX-JAPAN SHARES INDEX ETF - AUD ETF Vanguard FTSE Asia Ex-Japan Shares Index ETF - AUD
+15.03%0.04% 535 M€
XTRACKERS MSCI EMERGING MARKETS EX CHINA UCITS ETF 1C - GBP ETF Xtrackers MSCI Emerging Markets ex China UCITS ETF 1C - GBP
+36.73%0.04% 168 M€
ISHARES MSCI EM ASIA UCITS ETF - USD ETF iShares MSCI EM Asia UCITS ETF - USD
+27.00%0.04% 8,289 M€
ISHARES MSCI EM EX-CHINA UCITS ETF - USD DIST ETF iShares MSCI EM ex-China UCITS ETF - USD Dist
+38.11%0.04% 1,049 M€
ISHARES MSCI EMERGING MARKETS EX CHINA ETF - USD ETF iShares MSCI Emerging Markets ex China ETF - USD
+38.40%0.04% 24,558 M€
ISHARES MSCI EMERGING MARKETS EX CHINA INDEX ETF - CAD ETF iShares MSCI Emerging Markets ex China Index ETF - CAD
+39.99%0.04% 103 M€
STATE STREET SPDR S&P EMERGING MARKETS EX-CHINA ETF - USD ETF State Street SPDR S&P Emerging Markets ex-China ETF - USD
+20.93%0.04% 10 M€
JPMORGAN BETABUILDERS EMERGING MARKETS EQUITY ETF - USD ETF JPMorgan BetaBuilders Emerging Markets Equity ETF - USD
+21.28%0.04% 859 M€
FRANKLIN FTSE EMERGING MARKETS UCITS ETF - USD ETF Franklin FTSE Emerging Markets UCITS ETF - USD
-.--%0.04% 11 M€
GOLDMAN SACHS ACTIVEBETA EMERGING MARKETS EQUITY ETF - USD ETF Goldman Sachs ActiveBeta Emerging Markets Equity ETF - USD
+24.53%0.03% 1,699 M€
VANGUARD EMERGING MARKETS EX-CHINA ETF - USD ETF Vanguard Emerging Markets ex-China ETF - USD
+22.20%0.03% 268 M€
ISHARES MSCI EMERGING MARKETS ASIA ETF - USD ETF iShares MSCI Emerging Markets Asia ETF - USD
+24.88%0.03% 872 M€
WISDOMTREE EMERGING MARKETS EX-STATE-OWNED ENTERPRISES FUND - USD ETF WisdomTree Emerging Markets ex-State-Owned Enterprises Fund - USD
+22.66%0.03% 2,106 M€
12345

Company Profile

Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Sector
Pharmaceuticals
More about the company

Income Statement and Estimates

More financial data
  1. Stock Market
  2. Stocks
  3. ALKEM Stock
  4. ETFs Alkem Laboratories Limited
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong